$1.73 Billion is the total value of PURA VIDA INVESTMENTS, LLC's 197 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
New | SPDR S&P 500 ETF TRput | $44,648,000 | – | 125,000 | +100.0% | 2.58% | – | |
New | INVESCO QQQ TRput | $33,408,000 | – | 125,000 | +100.0% | 1.93% | – | |
New | UNITEDHEALTH GROUP INCput | $30,302,000 | – | 60,000 | +100.0% | 1.75% | – | |
New | STAAR SURGICAL COput | $26,104,000 | – | 370,000 | +100.0% | 1.51% | – | |
New | ADVISORSHARES TRcall | $20,089,000 | – | 2,254,700 | +100.0% | 1.16% | – | |
New | ICU MED INCcall | $18,825,000 | – | 125,000 | +100.0% | 1.09% | – | |
New | ILLUMINA INCcall | $16,217,000 | – | 85,000 | +100.0% | 0.94% | – | |
New | ELEVANCE HEALTH INCput | $15,898,000 | – | 35,000 | +100.0% | 0.92% | – | |
New | BOSTON BEER INCput | $12,946,000 | – | 40,000 | +100.0% | 0.75% | – | |
CYTK | New | CYTOKINETICS INC | $11,833,000 | – | 25,000 | +100.0% | 0.68% | – |
New | BAXTER INTL INCcall | $10,810,000 | – | 200,700 | +100.0% | 0.62% | – | |
ILMN | New | ILLUMINA INC | $10,493,000 | – | 55,000 | +100.0% | 0.61% | – |
ICUI | New | ICU MED INC | $9,413,000 | – | 62,500 | +100.0% | 0.54% | – |
New | VIEWRAY INCcall | $9,100,000 | – | 2,500,000 | +100.0% | 0.53% | – | |
New | TELADOC HEALTH INCput | $7,605,000 | – | 300,000 | +100.0% | 0.44% | – | |
OLK | New | OLINK HLDG ABsponsored ads | $7,523,000 | – | 619,723 | +100.0% | 0.44% | – |
New | BECTON DICKINSON & COput | $7,131,000 | – | 32,000 | +100.0% | 0.41% | – | |
New | HOLOGIC INCput | $7,097,000 | – | 110,000 | +100.0% | 0.41% | – | |
ABBV | New | ABBVIE INC | $6,711,000 | – | 50,000 | +100.0% | 0.39% | – |
New | IRHYTHM TECHNOLOGIES INCput | $5,888,000 | – | 47,000 | +100.0% | 0.34% | – | |
New | QUANTERIX CORPcall | $5,510,000 | – | 500,000 | +100.0% | 0.32% | – | |
New | ZIMMER BIOMET HOLDINGS INCcall | $5,228,000 | – | 50,000 | +100.0% | 0.30% | – | |
THC | New | TENET HEALTHCARE CORP | $5,158,000 | – | 100,000 | +100.0% | 0.30% | – |
TMDX | New | TRANSMEDICS GROUP INC | $5,009,000 | – | 120,000 | +100.0% | 0.29% | – |
New | STERIS PLCput | $4,988,000 | – | 30,000 | +100.0% | 0.29% | – | |
New | TANDEM DIABETES CARE INCcall | $4,785,000 | – | 100,000 | +100.0% | 0.28% | – | |
New | 2SEVENTY BIO INC | $4,729,000 | – | 325,000 | +100.0% | 0.27% | – | |
DXCM | New | DEXCOM INC | $4,567,000 | – | 56,700 | +100.0% | 0.26% | – |
New | NATERA INCcall | $4,382,000 | – | 100,000 | +100.0% | 0.25% | – | |
New | PFIZER INCcall | $4,376,000 | – | 100,000 | +100.0% | 0.25% | – | |
TERN | New | TERNS PHARMACEUTICALS INC | $4,291,000 | – | 728,600 | +100.0% | 0.25% | – |
New | MASIMO CORPcall | $4,235,000 | – | 30,000 | +100.0% | 0.24% | – | |
New | ESTABLISHMENT LABS HLDGS INCcall | $4,019,000 | – | 73,600 | +100.0% | 0.23% | – | |
SNY | New | SANOFIsponsored adr | $3,714,000 | – | 97,684 | +100.0% | 0.22% | – |
ISRG | New | INTUITIVE SURGICAL INC | $3,699,000 | – | 19,732 | +100.0% | 0.21% | – |
MASI | New | MASIMO CORP | $3,642,000 | – | 25,800 | +100.0% | 0.21% | – |
TNDM | New | TANDEM DIABETES CARE INC | $3,589,000 | – | 75,000 | +100.0% | 0.21% | – |
RMD | New | RESMED INC | $3,275,000 | – | 15,000 | +100.0% | 0.19% | – |
New | INARI MED INCput | $3,196,000 | – | 44,000 | +100.0% | 0.18% | – | |
LQDA | New | LIQUIDIA CORPORATION | $2,926,000 | – | 537,870 | +100.0% | 0.17% | – |
New | INTERCEPT PHARMACEUTICALS INcall | $2,790,000 | – | 200,000 | +100.0% | 0.16% | – | |
MRUS | New | MERUS N V | $2,717,000 | – | 135,632 | +100.0% | 0.16% | – |
New | SAREPTA THERAPEUTICS INCdebt 1.250% 9/1 | $2,586,000 | – | 25,000 | +100.0% | 0.15% | – | |
New | OAK STR HEALTH INCput | $2,452,000 | – | 100,000 | +100.0% | 0.14% | – | |
ANNX | New | ANNEXON INC | $2,315,000 | – | 374,630 | +100.0% | 0.13% | – |
PFE | New | PFIZER INC | $2,188,000 | – | 50,000 | +100.0% | 0.13% | – |
New | AMYRIS INCput | $2,044,000 | – | 700,000 | +100.0% | 0.12% | – | |
BSX | New | BOSTON SCIENTIFIC CORP | $1,884,000 | – | 48,635 | +100.0% | 0.11% | – |
RVMD | New | REVOLUTION MEDICINES INC | $1,873,000 | – | 95,000 | +100.0% | 0.11% | – |
NGM | New | NGM BIOPHARMACEUTICALS INC | $1,775,000 | – | 135,696 | +100.0% | 0.10% | – |
RXDX | New | PROMETHEUS BIOSCIENCES INC | $1,722,000 | – | 29,188 | +100.0% | 0.10% | – |
AKYA | New | AKOYA BIOSCIENCES INC | $1,733,000 | – | 147,500 | +100.0% | 0.10% | – |
New | KODIAK SCIENCES INCcall | $1,548,000 | – | 200,000 | +100.0% | 0.09% | – | |
New | GERON CORPput | $1,459,000 | – | 623,300 | +100.0% | 0.08% | – | |
MRTX | New | MIRATI THERAPEUTICS INC | $1,397,000 | – | 20,000 | +100.0% | 0.08% | – |
RETA | New | REATA PHARMACEUTICALS INCcl a | $1,397,000 | – | 55,596 | +100.0% | 0.08% | – |
IOVA | New | IOVANCE BIOTHERAPEUTICS INC | $1,385,000 | – | 144,528 | +100.0% | 0.08% | – |
New | ORAMED PHARMACEUTICALS INCcall | $1,202,000 | – | 185,500 | +100.0% | 0.07% | – | |
GERN | New | GERON CORP | $1,170,000 | – | 500,000 | +100.0% | 0.07% | – |
CERE | New | CEREVEL THERAPEUTICS HLDNG I | $1,163,000 | – | 41,136 | +100.0% | 0.07% | – |
ALKS | New | ALKERMES PLC | $1,117,000 | – | 50,000 | +100.0% | 0.06% | – |
VRNA | New | VERONA PHARMA PLCsponsored ads | $1,022,000 | – | 100,000 | +100.0% | 0.06% | – |
LLY | New | LILLY ELI & CO | $856,000 | – | 2,646 | +100.0% | 0.05% | – |
New | NGM BIOPHARMACEUTICALS INCcall | $789,000 | – | 60,300 | +100.0% | 0.05% | – | |
RCKT | New | ROCKET PHARMACEUTICALS INC | $798,000 | – | 50,000 | +100.0% | 0.05% | – |
New | NGM BIOPHARMACEUTICALS INCput | $785,000 | – | 60,000 | +100.0% | 0.04% | – | |
New | PROMETHEUS BIOSCIENCES INCput | $738,000 | – | 12,500 | +100.0% | 0.04% | – | |
CYTK | New | CYTOKINETICS INC | $727,000 | – | 15,000 | +100.0% | 0.04% | – |
AGLY | New | AGILITI INC | $704,000 | – | 49,200 | +100.0% | 0.04% | – |
BLUE | New | BLUEBIRD BIO INC | $504,000 | – | 79,604 | +100.0% | 0.03% | – |
QGEN | New | QIAGEN NV | $454,000 | – | 11,000 | +100.0% | 0.03% | – |
New | JOUNCE THERAPEUTICS INCcall | $426,000 | – | 182,200 | +100.0% | 0.02% | – | |
RNA | New | AVIDITY BIOSCIENCES INC | $302,000 | – | 18,506 | +100.0% | 0.02% | – |
New | PROVENTION BIO INCcall | $252,000 | – | 56,100 | +100.0% | 0.02% | – | |
New | ARDELYX INCcall | $238,000 | – | 200,000 | +100.0% | 0.01% | – | |
MGNX | New | MACROGENICS INC | $182,000 | – | 52,573 | +100.0% | 0.01% | – |
GLSI | New | GREENWICH LIFESCIENCES INC | $179,000 | – | 19,667 | +100.0% | 0.01% | – |
BIVI | New | BIOVIE INCcl a new | $91,000 | – | 36,617 | +100.0% | 0.01% | – |
ARDX | New | ARDELYX INC | $60,000 | – | 50,000 | +100.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ICU MED INC | 26 | Q2 2023 | 4.2% |
NANOSTRING TECHNOLOGIES INC | 26 | Q2 2023 | 3.3% |
VIEWRAY INC | 25 | Q2 2023 | 3.2% |
LIVANOVA PLC | 23 | Q3 2023 | 3.8% |
ALEXION PHARMACEUTICALS INC | 23 | Q1 2021 | 4.3% |
INSPIRE MED SYS INC | 22 | Q3 2023 | 3.7% |
BOSTON SCIENTIFIC CORP | 22 | Q3 2022 | 4.8% |
INVACARE CORP | 22 | Q3 2021 | 2.8% |
ESTABLISHMENT LABS HLDGS INC | 21 | Q3 2023 | 5.0% |
INTERSECT ENT INC | 21 | Q2 2021 | 2.6% |
View PURA VIDA INVESTMENTS, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Stryve Foods Holdings, LLC | April 19, 2023 | 1,470,649 | 5.6% |
ICAD INC | March 15, 2023 | 1,277,214 | 5.0% |
ESTABLISHMENT LABS HOLDINGS INC. | February 14, 2023 | 1,002,767 | 4.1% |
Pulmonx Corp | February 14, 2023 | 1,216,258 | 3.2% |
Quotient LtdSold out | February 14, 2023 | 0 | 0.0% |
Universe Pharmaceuticals INCSold out | February 14, 2023 | 0 | 0.0% |
MedMen Enterprises, Inc. | April 29, 2022 | 139,755,072 | 21.4% |
INVACARE CORPSold out | February 14, 2022 | 0 | 0.0% |
MedAvail Holdings, Inc. | February 14, 2022 | 714,120 | 2.2% |
TELA Bio, Inc. | February 14, 2022 | 564,120 | 3.9% |
View PURA VIDA INVESTMENTS, LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
13F-HR | 2024-02-13 |
SC 13D/A | 2023-12-29 |
View PURA VIDA INVESTMENTS, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.